Prostate Cancer

Association Between Medicaid Expansion and Insurance Status, Risk Group, Receipt, and Refusal of Treatment Among Men with Prostate Cancer. February 14, 2025

Long-Term Safety and Survival Outcomes of [225Ac]Ac-PSMA (Prostate-Specific Membrane Antigen) and [225Ac]Ac-/[177Lu]Lu-PSMA (TANDEM) Radioligand Therapy (PRLT) in Metastatic Castration-Resistant Prostate Cancer. February 14, 2025

Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal Therapy. February 14, 2025

Couple-based lifestyle intervention for minority prostate cancer survivors: a randomized feasibility trial. February 14, 2025

The Germline and Somatic Origins of Prostate Cancer Heterogeneity. February 14, 2025

Do trial benefits predict real-world gains in metastatic castration resistant prostate cancer. February 14, 2025

Biochemical response to neoadjuvant hormonal therapy predicts long-term prostate cancer survival outcomes after high-dose-rate brachytherapy with external beam radiotherapy. February 13, 2025

Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study. February 13, 2025

The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer. February 13, 2025

Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. February 13, 2025

Comprehensive Genome Profiling Test in Japanese Patients With Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study. February 13, 2025

Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups. February 12, 2025

MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS. February 12, 2025

The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer. February 12, 2025

Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis. February 12, 2025

Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial. February 12, 2025

Feasibility and Short-Term Safety of Hydrogel Spacer before Treatment with Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation for Prostate Cancer Treatment. February 12, 2025

Development of a deep learning system for predicting biochemical recurrence in prostate cancer. February 12, 2025

Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: a multicenter study. February 12, 2025

Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies. February 11, 2025

Page 1 of 1458